Collplant Biotechnologies Ltd - ADR (CLGN) has gained 0.17% in a Week, Should You Hold?

A rating of 90 puts Collplant Biotechnologies Ltd - ADR (CLGN) near the top of the Biotechnology industry according to InvestorsObserver. Collplant Biotechnologies Ltd - ADR's score of 90 means it scores higher than 90% of stocks in the industry. Collplant Biotechnologies Ltd - ADR also received an overall rating of 76, putting it above 76% of all stocks. Biotechnology is ranked 46 out of the 148 industries.

CLGN has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on CLGN!

See Full CLGN Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Collplant Biotechnologies Ltd - ADR Stock Today?

Collplant Biotechnologies Ltd - ADR (CLGN) stock has risen 2.13% while the S&P 500 is down -0.17% as of 2:00 PM on Friday, Feb 10. CLGN has risen $0.25 from the previous closing price of $11.72 on volume of 5,749 shares. Over the past year the S&P 500 is down -9.54% while CLGN has risen 18.87%. CLGN lost -$1.49 per share the over the last 12 months. Click Here to get the full Stock Report for Collplant Biotechnologies Ltd - ADR stock.